ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation (APC)

0,02
0,00
(0,00%)
Geschlossen 01 Februar 10:00PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,02
Gebot
0,015
Fragen
0,025
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
0,02
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

APC Neueste Nachrichten

Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma

VANCOUVER, British Columbia , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce very positive...

Advanced Proteome Therapeutics Reports Progress on Collaboration with Noria Pharmaceuticals

VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce the successful...

APC Comments on Favorable Results in Initial Animal Studies

VANCOUVER, British Columbia, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to report favorable results...

Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative

VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to report significant...

Advanced Proteome Therapeutics Provides Overview of Current Activities and Strategic Objectives

VANCOUVER, British Columbia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to provide an overview of...

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) --  Advanced Proteome Therapeutics...

Advanced Proteome Therapeutics Announces Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) --  Advanced Proteome Therapeutics...

Advanced Proteome Therapeutics Announces Collaboration with Noria Pharmaceuticals

VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8), is pleased to announce the collaboration...

Advanced Proteome Therapeutics Advances its Technological Capability

VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8), is pleased to report continuing progress...

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointment of...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

APC - Frequently Asked Questions (FAQ)

What is the current Advanced Proteome Therap... share price?
The current share price of Advanced Proteome Therap... is $ 0,02
What is the 1 year trading range for Advanced Proteome Therap... share price?
Advanced Proteome Therap... has traded in the range of $ 0,00 to $ 0,00 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BYM.HBaymount Incorporated
$ 0,015
(200,00%)
102k
FBR.HFibre Crown Manufacturing Inc
$ 0,12
(140,00%)
10k
MPTH.HMapath Capital Corp
$ 0,035
(133,33%)
1.000
MMNMonarca Minerals Inc
$ 0,01
(100,00%)
10k
GETTGETT Gold Inc
$ 0,02
(100,00%)
1,1k
EKGCardioComm Solutions Inc
$ 0,01
(-50,00%)
79k
ADEAdex Mining Inc
$ 0,005
(-50,00%)
21,1k
MVYMoovly Media Inc
$ 0,005
(-50,00%)
1,3M
MURMurchison Minerals Ltd
$ 0,01
(-33,33%)
10k
AOROAloro Mining Corp
$ 0,01
(-33,33%)
59k
GXUGoviEx Uranium Inc
$ 0,035
(-30,00%)
50,83M
AISXAisix Solutions Inc
$ 0,05
(42,86%)
6,56M
CYGCygnus Metals Limited
$ 0,12
(-7,69%)
4,8M
GPUSAlset AI Ventures Inc
$ 0,105
(10,53%)
4,43M
QNCQuantum Emotion Corp
$ 0,81
(6,58%)
3,16M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock